MSD India (as Merck & Co. Inc. is known outside of the US and Canada) has initiated legal proceedings against several Indian parties that are claimed to be producing its diabetes products Januvia (sitagliptin) and Janumet (sitagliptin/metformin hydrochloride), securing ex-parte injunctions from the Delhi High Court in two cases.
One of the alleged infringers, Mahaveer Chand, is said to be involved in contract manufacturing and export of generic version...